National Institute of Diabetes and Digestive and Kidney Diseases

From WikiMD's WELLNESSPEDIA

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is a part of the United States Department of Health and Human Services' National Institutes of Health (NIH). It is responsible for conducting and supporting basic and clinical research on some of the most serious and prevalent diseases affecting public health. The institute's research focuses on a wide range of conditions related to diabetes, digestive diseases, kidney diseases, obesity, nutritional disorders, and blood diseases. The NIDDK also addresses urologic diseases, with an aim to improve people's health and quality of life.

Mission and Goals[edit]

The mission of the NIDDK is to conduct and support medical research and research training to control and cure diseases related to its areas of focus. The institute aims to gather and disseminate research findings to increase knowledge and understanding about health and disease among patients, health professionals, and the public.

Research Areas[edit]

The NIDDK supports and conducts a broad range of research on diseases that are among the most chronic, costly, and consequential for patients, their families, and the nation. These areas include:

Funding and Grants[edit]

The NIDDK provides funding for research through grants, contracts, and cooperative agreements. It supports scientists in universities, medical schools, hospitals, and other research institutions across the United States and abroad. The institute also offers research training and career development programs to build the scientific workforce addressing diseases within its mission.

Public Health Information[edit]

In addition to research, the NIDDK provides a wealth of health information to the public, healthcare professionals, and researchers. This includes educational resources on the diseases within its purview, nutritional information, and guidelines for managing chronic conditions.

History[edit]

The NIDDK was established in 1950 as the National Institute of Arthritis and Metabolic Diseases. Over the years, its mission expanded to include research on diabetes, digestive and kidney diseases, leading to its current name and structure.

See Also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.